{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:34:29Z","timestamp":1787787269570,"version":"build-2784847793"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0219044","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T17:32:02Z","timestamp":1562175122000},"page":"e0219044","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Prognostic significance of serum albumin in patients with stable coronary artery disease treated by percutaneous coronary intervention"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9058-9258","authenticated-orcid":true,"given":"Sho","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kozuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Yahikozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"PG Steg","year":"2007","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2018.06.027","article-title":"Usefulness of higher levels of cardiac troponin t in patients with stable angina pectoris to predict risk of acute myocardial infarction","volume":"122","author":"V Vavik","year":"2018","journal-title":"Am J Cardiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.ijcard.2013.08.029","article-title":"Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention","volume":"168","author":"Y Kitai","year":"2013","journal-title":"Int J Cardiol"},{"key":"ref4","article-title":"Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention","author":"P Jiang","journal-title":"Cardiol. J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1161\/CIRCULATIONAHA.104.482570","article-title":"Biomarkers of cardiovascular disease: molecular basis and practical considerations","volume":"113","author":"RS Vasan","year":"2006","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"G Fanali","year":"2012","journal-title":"Mol Aspects Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies","volume":"279","author":"J Danesh","year":"1998","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"C Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/aje\/kwj312","article-title":"Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam","volume":"164","author":"BW Schalk","year":"2006","journal-title":"Am J Epidemiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ahj.2010.05.022","article-title":"Serum albumin concentration and heart failure risk the Health, Aging, and Body Composition Study","volume":"160","author":"DM Gopal","year":"2010","journal-title":"Am Heart J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0003319715575220","article-title":"Usefulness of serum albumin concentration to predict high coronary SYNTAX score and in-hospital mortality in patients with acute coronary syndrome","volume":"67","author":"A Kurtul","year":"2016","journal-title":"Angiology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.amjcard.2016.11.054","article-title":"Prognostic implications of serum albumin levels in patients with acute coronary syndromes","volume":"119","author":"H Gonz\u00e1lez-Pacheco","year":"2017","journal-title":"Am J Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MCA.0b013e32835c46fd","article-title":"The prognostic value of serum albumin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention","volume":"24","author":"V Oduncu","year":"2013","journal-title":"Coron Artery Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2017.04.003","article-title":"Association of low serum albumin concentration and adverse cardiovascular events in stable heart disease","volume":"241","author":"SC Chien","year":"2017","journal-title":"Int J Cardiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(89)92042-4","article-title":"Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes","volume":"2","author":"A Phillips","year":"1989","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-8703(92)90667-K","article-title":"Serum albumin, coronary heart disease, and death","volume":"123","author":"RF Gillum","year":"1992","journal-title":"Am Heart J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/oxfordjournals.aje.a116030","article-title":"The relation between serum albumin levels and risk of coronary heart disease in the multiple risk factor intervention trial","volume":"134","author":"LH Kuller","year":"1991","journal-title":"Am J Epidemiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e1000286","DOI":"10.1371\/journal.pmed.1000286","article-title":"Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease","volume":"7","author":"H Hemingway","year":"2010","journal-title":"PLoS Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","article-title":"Serum albumin: relationship to inflammation and nutrition","volume":"17","author":"BR Don","year":"2004","journal-title":"Semin Dial"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ahj.2007.11.043","article-title":"Albumin levels predict survival in patients with systolic heart failure","volume":"155","author":"TB Horwich","year":"2008","journal-title":"Am Heart J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jada.2004.05.213","article-title":"Hepatic proteins and nutrition assessment","volume":"104","author":"MP Fuhrman","year":"2004","journal-title":"J Am Diet Assoc"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.104.508465","article-title":"C-reactive protein in heart failure: prognostic value and the effect of valsartan","volume":"112","author":"IS Anand","year":"2005","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)","volume":"103","author":"A Deswal","year":"2001","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.CIR.97.12.1136","article-title":"Elevated circulating levels of C-C chemokines in patients with congestive heart failure","volume":"97","author":"P Aukrust","year":"1998","journal-title":"Circulation"},{"key":"ref25","first-page":"1","article-title":"Prognostic efficacy of C-reactive protein\/albumin ratio in ST elevation myocardial infarction","volume":"5","author":"T \u00c7\u0131nar","year":"2019","journal-title":"Scand Cardiovasc J"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"e22457","DOI":"10.1002\/jcla.22457","article-title":"Relationship between C-reactive protein\/albumin ratio and coronary artery disease severity in patients with stable angina pectoris","volume":"32","author":"Y Karaba\u011f","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"P Libby","year":"2002","journal-title":"Circulation"},{"key":"ref28","first-page":"2129","article-title":"Leducq Transatlantic Network on Atherothrombosis","volume":"54","author":"P Libby","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"R Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0735-1097(98)00487-2","article-title":"HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis","volume":"32","author":"C Bustos","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.103.2.276","article-title":"An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro","volume":"103","author":"M Aikawa","year":"2001","journal-title":"Circulation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0219044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:36:38Z","timestamp":1589042198000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0219044"}},"subtitle":[],"editor":[{"given":"Chiara","family":"Lazzeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0219044","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]}}}